22
Hyperbaric oxygen therapy use in patients receiving dental implants at risk for osteoradionecrosis Tom Sarna 2/23/07 Chicago’s Midwinter Meeting

Hyperbaric oxygen use in treatment of ORN

Embed Size (px)

DESCRIPTION

 

Citation preview

Page 1: Hyperbaric oxygen use in treatment of ORN

Hyperbaric oxygen therapy use in patients receiving dental implants

at risk for osteoradionecrosis

Tom Sarna2/23/07

Chicago’s Midwinter Meeting

Page 2: Hyperbaric oxygen use in treatment of ORN

Implants

• Introduced by Branemark

• First titanium implant placed in a human volunteer in 1965.

• Commercially introduced in 1978.

• First intraoral application in 1979.

• Principle of osseointegration makes implants possible.

Page 3: Hyperbaric oxygen use in treatment of ORN

Osseointegration

• Def: Direct structural and functional connection between ordered and living bone and surface of load carrying implant.

• An additional clarification that there is direct connection between the bone and the titanium with no fibrous encapsulation.

• Fibrous encapsulated implants will be eventually lost.

Page 4: Hyperbaric oxygen use in treatment of ORN

6 factors for osseointegration

• Material biocompatibility

• lmplant macrostructure

• Implant microstructure

• Surgical technique

• Status of the implant bed

• Loading conditions

Page 5: Hyperbaric oxygen use in treatment of ORN

Osteoradionecrosis (ORN)

• Most frequently occurs in the mandible• A metabolic and tissue homeostatic deficiency

due to radiation-induced cellular injury• Ischemic necrosis of bone – Histopathology

shows dominant factor is obliteration of inferior alveolar artery.

• Although microorganisms plays a role in contamination of ORN bone, osteomyelitis differs from ORN.

Page 6: Hyperbaric oxygen use in treatment of ORN

Histopathology of ORN

• 3 H’s - Hypocellular bone– Hypovascular tissue

– Hypoxic tissue/bone

• Osteoclast activity reduced• Osteoblast numbers reduced =collagen

production decreased• Bone marrow suffers vascular injury

– Arteritis of small caliber vessels– Sclerosis of connective tissue– Alteration of nutritional supply

Page 7: Hyperbaric oxygen use in treatment of ORN

Adjunctive Treatment for Irradiated Patients

• Antibiotics– Penicillin pre/post surgery– Tetracycline 100 mg daily prophylaxis

• Saline rinses

• Hyperbaric oxygen use

Page 8: Hyperbaric oxygen use in treatment of ORN

Hyperbaric oxygen therapy

• Does not affect necrotic bone

• Target is the viable bone and soft tissue

• Goal is to revascularize radiated tissues and to improve fibroblastic density

• Healing process requires oxygen for:– Differentiation of fibroblasts– Synthesis of collagen

Page 9: Hyperbaric oxygen use in treatment of ORN

Marx protocol

• 20 “dives” before treatment/10 “dives” after treatment

• “Dives” - The slang term for a cycle of pressurization inside the HBOT chamber

• regimen of oxygen at 2.5-2.8 absolute atmosphere pressure (ATA) for 90-120 minutes.

Page 10: Hyperbaric oxygen use in treatment of ORN

HBO2 Risks

• Mild problems : claustrophobia (in monoplace chambers), fatigue, and headache.

• More serious complications: myopia (short sightedness) that can last for weeks or months, sinus damage, ruptured middle ear, and lung damage.

• Major complication: oxygen toxicity can result in convulsions, fluid in the lungs, and even respiratory failure.

Page 11: Hyperbaric oxygen use in treatment of ORN

Hyperbaric oxygen therapy

• The only absolute contraindication to hyperbaric oxygen therapy is untreated pneumothorax. Relative complications include grand mal seizure, fever, the inability to clear the ears or sinuses.

• Promoting angiogenesis in tumor cells is also a risk factor in HBO therapy

Page 12: Hyperbaric oxygen use in treatment of ORN

HBO induced angiogenesis

• Marx demostrated a measurable change in angiogenesis after eight sessions

• Plateau at 80% to 85% of nonirradiated tissue level after twenty sessions

• After three years, tissue O2 levels were within 90% of original values suggesting that HBO induced angiogenesis does not regress with time significantly.

Page 13: Hyperbaric oxygen use in treatment of ORN

Study: Granstrom 1999, Osseointegrated implants in

irradiated bone

• 4 groups• A: irradiated: 32 patients/ 147 implants

placed/79 lost (53% failure)• B: nonirradiated: 26 patients/ 89 implants/12 lost

(13.5% failure)• C: irradiated + HBO use: 20 patients/99

implants/8 lost (8.1% failure)• D: irradiated failed, retreated after HBO use:10

patients/43 implants/34 lost 1st (79% failure) / 5 lost 2nd (11.9% failure)

Page 14: Hyperbaric oxygen use in treatment of ORN

Study: Granstrom 1999, Osseointegrated implants in

irradiated bone analysis• No differentation between when implants

are placed after irradiation – a good determinate of success rate

• Also, later placement helps explain the great improvement in success rate of Group D (79%/12%)

Page 15: Hyperbaric oxygen use in treatment of ORN

Merickse-Stern 1999 25 patients – 53 implants after irradiation without hyperbaric oxygen

2 y survival 93.9 %

3 y survival 90.5%

5 y survival 90.5%

Page 16: Hyperbaric oxygen use in treatment of ORN

Merickse-Stern 1999

Shows a good success rate without hyperbaric oxygen in implant placement in irradiated bone

Page 17: Hyperbaric oxygen use in treatment of ORN

Weischer 1999 “Ten-Year Experience in Oral Implant

Rehabilitation• Irradiated patients vs. nonirradiated

patients

• Small sample size irradiated patients (17 patients, 73 implants)

• No hyperbaric oxygen control group

Page 18: Hyperbaric oxygen use in treatment of ORN

Weischer 1999 “Ten-Year Experience in Oral Implant

Rehabilitation• Encouraging success rate of clinically

osseointegrated implants in both irradiated and nonirradiated patients

• 75% success rate after 7 years in irradiated patients

• 86% success rate after 10 years in nonirradiated patients

Page 19: Hyperbaric oxygen use in treatment of ORN

Niimi 1998

• Implants placed between 2-10 years are more successful

• Longer implants are more successful• There were no failures of mandibular

implants with or without adjunctive HBO therapy

• Higher doses of radiation lead to poorer success rates

• Very little data for maxillary implants

Page 20: Hyperbaric oxygen use in treatment of ORN

Wagner, 1998 “ Osseointegration of implants in irradiated patient”

• No hyperbaric oxygen use

• 275 implants in 63 irradiated patients

• Osteoradionecrosis: 1.6%

1 patient out of 62

• Osseointegration: 97.9%

• 269 implants out of 275

Page 21: Hyperbaric oxygen use in treatment of ORN

Summary of implant studies in irradiated bone

• Attraumatic surgery is best determinate of healing without ORN

• Good success rate without hyperbaric oxygen• Higher success rate when combined with

hyperbaric oxygen • Rarely is osteoradionecrosis caused by implant

surgery, studies analyze success rate of osseointegration

• Should wait at least 1.5 years after irradiation to place implants

Page 22: Hyperbaric oxygen use in treatment of ORN

Hyperbaric oxygen centers in Chicago

Arlington Heights Longevity Institute

Arlington Heights, IL

Lutheran General Hospital

Park Ridge, IL

Midwest Hyperbaric InstituteBolingbrook, IL

Swedish Covenant Hospital – Wound Care Center

5145 N. CaliforniaChicago, IL